Impact of Infections on Long-Term Results after Heart Transplantation

被引：0
作者：
Doesch, A. O. [1 ]
机构：
[1] Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany
来源：
THORACIC AND CARDIOVASCULAR SURGEON | 2009年 / 57卷
关键词：
CMV INFECTION; RECIPIENTS; CYTOMEGALOVIRUS; DISEASE; PROPHYLAXIS; TRIAL; BLOOD; RISK; LOAD;
D O I：
10.1055/s-2008-1039251
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 12 条
[1]   Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality [J].
Arora, Satish ;
Jenum, Pal A. ;
Aukrust, Pal ;
Rollag, Halvor ;
Andreassen, Arne K. ;
Simonsen, Svein ;
Gude, Einar ;
Fiane, Arnt E. ;
Geiran, Odd ;
Gullestad, Lars .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (20) :1967-1972
[2]   Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction [J].
Benden, C ;
Aurora, P ;
Burch, M ;
Cubitt, D ;
Lloyd, C ;
Whitmore, P ;
Neligan, SL ;
Elliott, MJ .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12) :2103-2108
[3]   Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1β [J].
Dengler, TJ ;
Raftery, MJ ;
Werle, M ;
Zimmermann, R ;
Schönrich, G .
TRANSPLANTATION, 2000, 69 (06) :1160-1168
[4]   Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients [J].
Doesch, Andreas O. ;
Konstandin, Mathias ;
Celik, Sultan ;
Kristen, Arnt ;
Frankenstein, Lutz ;
Sack, Falk-Udo ;
Schnabel, Philipp ;
Schnitzler, Paul ;
Katus, Hugo A. ;
Dengler, Thomas J. .
TRANSPLANT INTERNATIONAL, 2008, 21 (10) :963-971
[5]   Medical progress: Infection in solid-organ transplant recipients [J].
Fishman, Jay A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (25) :2601-2614
[6]   Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients [J].
Kalil, AC ;
Levitsky, J ;
Lyden, E ;
Stoner, J ;
Freifeld, AG .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (12) :870-880
[7]   Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial [J].
Kliem, V. ;
Fricke, L. ;
Wollbrink, T. ;
Burg, M. ;
Radermacher, J. ;
Rohde, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) :975-983
[8]   A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. [J].
Martin, DF ;
Sierra-Madero, J ;
Walmsley, S ;
Wolitz, RA ;
Macey, K ;
Georgiou, P ;
Robinson, CA ;
Stempien, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1119-1126
[9]   Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers [J].
Maurmann, S ;
Fricke, L ;
Wagner, HJ ;
Schlenke, P ;
Hennig, H ;
Steinhoff, J ;
Jabs, WJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5419-5428
[10]   Lymphomas after solid organ transplantation:: A collaborative transplant study report [J].
Opelz, G ;
Döhle, B .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) :222-230
12